Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
We describe six patients (five women and one man; median age, 47 years; range, 39 to 54) with postprandial symptoms of neuroglycopenia owing to endogenous hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery. Except for equivocal evidence in one patient, there was no radiologic evidence of insulinoma. Selective arterial calcium-stimulation tests, positive in each patient, were used to guide partial pancreatectomy. Nesidioblastosis was identified in resected specimens from each patient, and multiple insulinomas were identified in one. Hypoglycemic symptoms diminished postoperatively. We speculate that hyperfunction of pancreatic islets did not lead to obesity but that beta-cell trophic factors may have increased as a result of gastric bypass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some persons who have undergone Roux-en-Y gastric bypass for obesity have endogenous hyperinsulinemic hypoglycemia most often due to pancreatic islet nesidioblastosis, but occasionally due to an insulinoma (48 -50).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“However, it is the procedure of choice for confirming noninsulinoma pancreatogenous hypoglycemia (15,(43)(44)(45) and post Roux-en-Y gastric bypass hypoglycemia (48 -50) because standard imaging is negative in those disorders.”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [48]
In the citing paper
“post-RYGB hyperinsulinemic hypoglycemia may involve β-cell hypertrophy or neogenesis as well ( 80 , 81 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [80]
Citations
Cites
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664
Steinbrook, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048029 · Cited by 592
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
The Escalating Pandemics of Obesity and Sedentary Lifestyle: A Call to Action for Clinicians
Manson, J. E., Skerrett, P. J., Greenland, P., & VanItallie, T. B. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.249 · Cited by 504
Solcia, E., Capella, C., & Klöppel, G. (1997) · Medical Entomology and Zoology · Cited by 481
Zhou, J., Wang, X., Pineyro, M. A., & Egan, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319
Foulis, A. K. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<227::aid-path103>3.0.co;2-r · Cited by 212
Service, F. J., Natt, N., Thompson, G. B., Grant, C. S., van Heerden, J. A., Andrews, J. C., Lorenz, E., Terzic, A., & Lloyd, R. V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5645 · Cited by 196
Self-citationSigstad, H. (1970) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1970.tb08072.x · Cited by 176
Research works printed but not linked: 3
- Threatte GA, Henry JB. Carbohydrates. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. 19th ed. Philadelphia: W.B. Saunders, 1996:194-207.
- Kao PC, 1992, Ann Clin Lab Sci, 22, 307
- Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. Philadelphia: W.B. Saunders, 1999:750-808.
Cited by
Items 201–300 of 786
González-González, A., Delgado‐Rodríguez, M., & Fraga-Fuentes, M. D. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.05.010 · Cited by 51
Gastrointestinal surgery as treatment for type 2 diabetes
Moo, T.-A. S., & Rubino, F. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f88a0a · Cited by 53
Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells
Maffei, A., Segal, A. M., Álvarez-Pérez, J. C., García-Ocaña, A., & Harris, P. E. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1273 · Cited by 50
Molecular imaging in the investigation of hypoglycaemic syndromes and their management.
Pattison, D., & Hicks, R. (2017) · Endocrine-Related Cancer · doi:10.1530/erc-17-0005 · Cited by 43
Lee, C. J., Brown, T. T., Schweitzer, M., Magnuson, T., & Clark, J. M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.028 · Cited by 49
Role of the gastroenterologist in managing obesity
DiBaise, J. K., & Foxx–Orenstein, A. E. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.811061 · Cited by 52
Risk Factors for Spontaneously Self-Reported Postprandial Hypoglycemia After Bariatric Surgery
Nannipieri, M., Belligoli, A., Guarino, D., Busetto, L., Moriconi, D., Fabris, R., Mari, A., Baldi, S., Anselmino, M., Foletto, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1143 · Cited by 47
Craig, C. M., Liu, L., Nguyen, T., Price, C., Bingham, J., & McLaughlin, T. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13078 · Cited by 48
Insulin secretion and insulin-producing tumors
Guettier, J., & Görden, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.83 · Cited by 55
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery
Mingrone, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.004 · Cited by 54
Botros, N., Rijnaarts, I., Brandts, H., Bleumink, G. S., Janssen, I. M. C., & de Boer, H. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1319-6 · Cited by 52
Jiménez, A., Ceriello, A., Casamitjana, R., Flores, L., Viaplana-Masclans, J., & Vidal, J. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000586 · Cited by 51
Laparoscopic Enucleation of Insulinomas
Sweet, M. P. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.12.1202 · Cited by 48
Surgical Management of Morbid Obesity
Tessier, D. J., & Eagon, J. C. (2008) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2007.12.003 · Cited by 47
DRAVECKA, I., & LAZUROVA, I. (2014) · Neoplasma · doi:10.4149/neo_2014_047 · Cited by 45
Novel preparations of glucagon for the prevention and treatment of hypoglycemia
Hawkes, C. P., De Leon, D. D., & Rickels, M. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1216-4 · Cited by 46
Starke, A., Saddig, C., Kirch, B., Tschahargane, C., & Goretzki, P. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0543-6 · Cited by 46
Nutrition and Metabolic Complications After Bariatric Surgery and Their Treatment
Fujioka, K., DiBaise, J. K., & Martindale, R. G. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111413600 · Cited by 50
The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
Guida, C., Stephen, S., Guitton, R., & Ramracheya, R. D. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.04.005 · Cited by 49
Hyperinsulinaemic Hypoglycaemia
Arya, V. B., Mohammed, Z. K., Blankenstein, O., de Lonlay, P., & Hussain, K. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1367063 · Cited by 50
Hypoglycaemia following gastric bypass surgery—diabetes remission in the extreme?
Patti, M., & Goldfine, A. B. (2010) · Diabetologia · doi:10.1007/s00125-010-1884-8 · Cited by 50
“Intriguingly, pancreatic histology from some patients with neuroglycopenia suggests the possibility of islet expansion (so-called ‘nesidioblastosis’) [7, 8].”
BackgroundGlycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB)
Lee, D., Dreyfuss, J. M., Sheehan, A., Puleio, A., Mulla, C. M., & Patti, M. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab323 · Cited by 45
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
Haris, B., Saraswathi, S., & Hussain, K. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820965068 · Cited by 56
Alsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 53
Mulla, C. M., Zavitsanou, S., Laguna Sanz, A. J., Pober, D., Richardson, L., Walcott, P., Arora, I., Newswanger, B., Cummins, M. J., Prestrelski, S. J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz197 · Cited by 43
Severe hypoglycemia after gastric bypass surgery for morbid obesity
Abellán, P., Cámara, R., Merino-Torres, J. F., Pérez-Lazaro, A., del Olmo, M. I., Ponce, J. L., Rayón, J. M., & Piñón, F. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.017 · Cited by 44
Hypoglycaemia after gastric bypass: mechanisms and treatment
Ritz, P., Vaurs, C., Barigou, M., & Hanaire, H. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12592 · Cited by 41
Daniels, G. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00002-x · Cited by 42
Pigeyre, M., Vaurs, C., Raverdy, V., Hanaire, H. P., Ritz, P., & Pattou, F. N. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.004 · Cited by 42
“The mechanism of postbypass hypoglycemia has been the matter of debate, with some authors considering that it results from pancreatic β-cell hyperplasia, while others refute this argument [6–13].”
BackgroundHanaire, H. P., Dubet, A., Chauveau, M.-E., Anduze, Y., Fernandes, M., Melki, V., & Ritz, P. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9975-7 · Cited by 42
Adverse effects during the oral glucose tolerance test in post-bariatric surgery patients
Andrade, H. F. D. A., Pedrosa, W., Diniz, M. D. F. H. S., & Passos, V. M. D. A. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000149 · Cited by 43
Emerging Concepts in the Medical and Surgical Treatment of Obesity
Aylwin, S., & Al-Zaman, Y. (2008) · Frontiers of Hormone Research · doi:10.1159/000115368 · Cited by 41
Surgical Management of Pancreatic Neuroendocrine Tumors
Clancy, T. E. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.09.004 · Cited by 41
Insulinoma After Bariatric Surgery: Diagnostic Dilemma and Therapeutic Approaches
Mulla, C. M., Storino, A., Yee, E. U., Lautz, D., Sawnhey, M. S., Moser, A. J., & Patti, M.-E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2092-5 · Cited by 40
How common is hypoglycemia after gastric bypass?
Goldfine, A. B., & Patti, M. E. (2016) · Obesity · doi:10.1002/oby.21520 · Cited by 38
Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update
Øhrstrøm, C. C., Worm, D., & Hansen, D. L. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.09.025 · Cited by 42
Ciudin, A., Sanchez, M. J. B., Hernández, I., Cordero-Vázquez, E., Fidilio, E., Comas, M., Gonzalez, C., Lopez, N., Vilallonga, R., Giralt, M., et al. (2021) · Obesity Facts · doi:10.1159/000515598 · Cited by 40
Sheehan, A., & Patti, M. E. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s233078 · Cited by 39
Best Practice Updates for Nursing Care in Weight Loss Surger
Mulligan, A. T., McNamara, A., Boulton, H. R. W., Trainor, L. S., Raiano, C., & Mullen, A. (2009) · Obesity · doi:10.1038/oby.2008.579 · Cited by 39
Neonatal hyperinsulinism: clinicopathologic correlation
Delonlay, P., Simon, A., Galmiche, L., Giurgea, I., Verkarre, V., Aigrain, Y. Y., Ribeiro, M.-J., Polak, M., Robert, J., Bellanné‐Chantelot, C., et al. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.12.007 · Cited by 42
Laurenius, A., Werling, M., le Roux, C. W., Fändriks, L., & Olbers, T. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.04.007 · Cited by 40
“Partial or total pancreatectomy are currently not considered appropriate since symptoms do not always improve or may reoccur, even if β-cell mass is decreased [19–22].”
BackgroundRoslin, M. S., Dudiy, Y., Brownlee, A. R., Weiskopf, J., & Shah, P. C. (2013) · Surgical Endoscopy · doi:10.1007/s00464-013-3176-0 · Cited by 43
Itariu, B. K., Zeyda, M., Prager, G., & Stulnig, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094613 · Cited by 40
Vanderveen, K. A., & Grant, C. S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_13 · Cited by 38
A Simple Matter of Life and Death—The Trials of Postnatal Beta-Cell Mass Regulation
Tarabra, E., Pelengaris, S., & Khan, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/516718 · Cited by 40
“However, while there are reports of GLP-1-mediated islet neogenesis [98, 106–109], recent statements by researchers examining the in vivo effects of GLP-1 call into question a neogenic response [110–112].”
BackgroundIs the Gut the “Sweet Spot” for the Treatment of Diabetes?
Rubino, F., & Amiel, S. A. (2014) · Diabetes · doi:10.2337/db14-0402 · Cited by 41
Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period
Padidela, R., Patterson, M., Sharief, N., Ghatei, M. A., & Hussain, K. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0807 · Cited by 44
Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health
Miras, A. D., & le Roux, C. W. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70158-x · Cited by 40
Dapri, G., Cadière, G. B., & HIMPENS, J. M. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0249-1 · Cited by 37
“Finally, the hyperinsulinemic status is reported to possibly evolves into beta-cell hyperplasia [18] and even nesidioblastoma [19].”
BackgroundImpact of Postprandial Hypoglycemia on Weight Loss After Bariatric Surgery
Rebelos, E., Moriconi, D., Scalese, M., Denoth, F., Molinaro, S., Siciliano, V., Anselmino, M., Taddei, S., Ferrannini, E., & Nannipieri, M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04465-9 · Cited by 39
Impact of bariatric surgery on type 2 diabetes
Meneghini, L. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0020-y · Cited by 39
“A few recent reports have ascribed post-prandial hypoglycemia following gastric bypass surgery to the finding of nesidioblastosis on pathology reports of partially pancreatectomized subjects [24–25].”
BackgroundKandel, D., Bojsen-Møller, K. N., Svane, M. S., Samkani, A., Astrup, A., Holst, J. J., Madsbad, S., & Krarup, T. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy310 · Cited by 34
Fischer, L. E., Wolfe, B. M., Fino, N., Elman, M. R., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Purnell, J. Q., Patti, M.-E., et al. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.04.021 · Cited by 36
Type 2 Diabetes Mellitus: A Possible Surgically Reversible Intestinal Dysfunction
Sala, P. C., Torrinhas, R. S., Heymsfield, S. B., & Waitzberg, D. L. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0563-2 · Cited by 41
Hypoglycemia Following Bariatric Surgery: Our 31-Year Experience
Michaels, A. D., Hunter Mehaffey, J., Brenton French, W., Schirmer, B. D., Kirby, J. L., & Hallowell, P. T. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2734-2 · Cited by 34
A Rare Case of Adult-onset Nesidioblastosis Treated Successfully with Diazoxide
ARAO, T., OKADA, Y., HIROSE, A., & TANAKA, Y. (2006) · Endocrine Journal · doi:10.1507/endocrj.53.95 · Cited by 36
Surgical Treatment for Morbid Obesity: The Laparoscopic Roux-en-Y Gastric Bypass
Powell, M. S., & Fernandez, A. (2011) · Surgical Clinics of North America · doi:10.1016/j.suc.2011.08.013 · Cited by 45
Li, B., Lu, Y., Srikant, C. B., Gao, Z., & Liu, J. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00275.2012 · Cited by 39
Post‐gastric bypass hypoglycaemia: a review
Shantavasinkul, P. C., Torquati, A., & Corsino, L. (2016) · Clinical Endocrinology · doi:10.1111/cen.13033 · Cited by 41
Successful Treatment of Persistent Hyperinsulinemic Hypoglycemia with Nifedipine in an Adult Patient
Guseva, N., Phillips, D., & Mordes, J. P. (2010) · Endocrine Practice · doi:10.4158/ep09110.crr · Cited by 35
Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes
Kota, S. K., Ugale, S. M., Gupta, N., & Modi, K. D. (2012) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.09.014 · Cited by 38
Fatal Hyperammonemic Encephalopathy After Gastric Bypass Surgery
Fenves, A. Z., Boland, C. R., Lepe, R., Rivera-Torres, P., & Spechler, S. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.032 · Cited by 34
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
Brix, J. M., Kopp, H.-P., Höllerl, F., Schernthaner, G.-H., Ludvik, B. H., & Schernthaner, G. (2019) · Obesity Facts · doi:10.1159/000493735 · Cited by 34
Akalestou, E., Suba, K., López–Noriega, L., Georgiadou, E., CHABOSSEAU, P. L., Gallie, A., Wretlind, A., Legido‐Quigley, C., Leclerc, I., Salem, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25423-8 · Cited by 34
Metabolic Aspects of Bariatric Surgery
Folli, F. B., Pontiroli, A. E., & Schwesinger, W. H. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.01.005 · Cited by 37
Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery
(2005) · New England Journal of Medicine · doi:10.1056/nejm200511173532017 · Cited by 34
Surgical Management of Pancreatic Neuroendocrine Tumors
Liu, J. B., & Baker, M. S. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.07.002 · Cited by 33
de Heide, L. J. M., Laskewitz, A. J., & Apers, J. A. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.11.006 · Cited by 33
Parsaik, A. K., Carter, R. E., Pattan, V., Myers, L. A., Kumar, H., Smith, S. A., Russi, C. S., Levine, J. A., Basu, A., & Kudva, Y. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600109 · Cited by 33
Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes
Näslund, E. B., & Kral, J. G. (2006) · Diabetes · doi:10.2337/db06-s012 · Cited by 36
Clinical Features and Causes of Endogenous Hyperinsulinemic Hypoglycemia in Korea
Woo, C.-Y., Jeong, J. Y., Jang, J. E., Leem, J., Jung, C. H., Koh, E. H., Lee, W. J., Kim, M.-S., Park, J.-Y., Lee, J. B., et al. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.2.126 · Cited by 32
“ioblastosis, a disease characterized by pancreatic β-cell hyperplasia and hypertrophy, is usually reported in infants but is rare in adults [4,5].”
BackgroundResultInfluentialHypoglycaemia following upper gastrointestinal surgery: case report and review of the literature
Bernard, B., Kline, G. A., & Service, F. J. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-77 · Cited by 32
“Recently, trophic factors and modulators of pancreatic morphology such as glucagon-like peptide 1 (GLP1) and islet neogenesis-associated protein (INGAP) have been implicated in the proposed pathologic changes leading to nesidioblastosis following upper gastrointestinal surgery [4,6,8-10].”
BackgroundSelf-citationCommon and Rare Complications of Bariatric Surgery
Collazo–Clavell, M. L., & Shah, M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.02.003 · Cited by 33
Self-citationNichols, C. G., York, N., & Remedi, M. S. (2022) · Diabetes · doi:10.2337/db21-0755 · Cited by 34
Liu, S., Zhang, G., Wang, L., Sun, D., Chen, W., Yan, Z., Sun, Y. S., & Hu, S. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826c3866 · Cited by 32
The role of Islet Neogenesis-Associated Protein (INGAP) in islet neogenesis
Lipsett, M. A., Hanley, S. C., Castellarin, M. L., Austin, E. B., Suarez‐Pinzon, W. L., Rabinovitch, A., & Rosenberg, L. C. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0028-3 · Cited by 33
“growth factor (EGF) [20, 22, 27], a peptide fragment of the RegIII protein islet neogenesis-associated protein (INGAP peptide) [12, 28, 29], glucagon-like peptide-1 (GLP1) [30– 32], and exendin-4 [33–37], although recent findings call into question the neogenic capacity in humans of the latter [38–40].”
BackgroundObesity-related cardiorenal disease: the benefits of bariatric surgery
Fenske, W. K., Athanasiou, T., Harling, L., Drechsler, C., Darzi, A. W., & Ashrafian, H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.145 · Cited by 35
Aromatic L-Amino Acid Decarboxylase Deficiency Is a Cause of Long-Fasting Hypoglycemia
Arnoux, J., Damaj, L., Napuri, S., Serre, V., Hubert, L., Cadoudal, M., Simard, G., Ceballos-Picot, I., Christa, L., & de Lonlay, P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2740 · Cited by 32
Vaurs, C., Brun, J. ‐., Bertrand, M., Burcelin, R., du Rieu, M. C., Anduze, Y., Hanaire, H. P., & Ritz, P. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.020 · Cited by 34
Approach to the Patient with Postprandial Hypoglycemia
Galati, S.-J., & Rayfield, E. J. (2013) · Endocrine Practice · doi:10.4158/ep13132.ra · Cited by 35
Bariatric surgery for diabetes management
Frachetti, K. J., & Goldfine, A. B. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832912e7 · Cited by 36
Kassem, M. A. M., Durda, M. A., Stoicea, N., Cavus, O., Sahin, L., & Rogers, B. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00037 · Cited by 38
[Nutritional implications of bariatric surgery on the gastrointestinal tract].
Rubio, M. Á., & Moreno, C. C. L. (2007) · Nutrición Hospitalaria · Cited by 31
Short- and Long-Term Surgical Follow-Up of the Postbariatric Surgery Patient
Frank, P. N., & Crookes, P. F. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.12.011 · Cited by 31
Eckert‐Norton, M., & Kirk, S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-v98i10-39a · Cited by 32
Postprandial hypoglycaemia after Roux-en-Y gastric bypass in individuals with type 2 diabetes
Guarino, D., Moriconi, D., Mari, A., Rebelos, E., Colligiani, D., Baldi, S., Anselmino, M., Ferrannini, E., & Nannipieri, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4737-5 · Cited by 32
Hypoglycemia after gastric bypass surgery
Singh, E., & Vella, A. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.217 · Cited by 30
Comparison Between RYGB, DS, and VSG Effect on Glucose Homeostasis
Roslin, M. S., Dudiy, Y., Weiskopf, J., Damani, T., & Shah, P. C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0686-0 · Cited by 32
Garibay, D., Lou, J., Lee, S. A., Zaborska, K. E., Weissman, M. H., Sloma, E. A., Donahue, L. R., Miller, A. D., White, A. C., Michael, M. D., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.120 · Cited by 30
Fleming, A., & Rosenberg, L. C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100214 · Cited by 34
Nesidioblastosis no longer! It's all about genetics.
Palladino, A., & Stanley, C. (2011) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2011-0164 · Cited by 28
Clinical Presentation and Diagnostic Approach to Hypoglycemia in Adults Without Diabetes Mellitus
Palani, G., Stortz, E., & Moheet, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2022.11.010 · Cited by 29
Bariatric surgery: a cure for diabetes?
Varela, J. E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283468e50 · Cited by 29
Thompson, S. M., Vella, A. V., Service, F. J., Grant, C. S., Thompson, G. B., & Andrews, J. C. (2015) · Surgery · doi:10.1016/j.surg.2015.03.004 · Cited by 30
Self-citationGlucagon Treatment for Post‐Gastric Bypass Hypoglycemia
Halperin, F., Patti, M. E., & Goldfine, A. B. (2010) · Obesity · doi:10.1038/oby.2010.15 · Cited by 29
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery
Malin, S. K., & Kashyap, S. R. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0151-1 · Cited by 34
Roslin, M. S., Gagner, M., Goriparthi, R., & Mitzman, B. A. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.11.017 · Cited by 31
“In fact, entities, such as the noninsulinoma-pancreatogenous syndrome and nesidioblastosis after RYGB, have been the subject of an increasing number of publications [28,29].”
BackgroundThe Great Debate: Medicine or Surgery
Lautz, D. B., Halperin, F., GOEBEL-FABBRI, A. E., & Goldfine, A. B. (2011) · Diabetes Care · doi:10.2337/dc10-1859 · Cited by 31
Metadata
- Authors
- Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V.
- Affiliations
- Mayo Clinic (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-07-21
- Volume
- 353
- Issue
- 3
- Pages
- 249-254
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2134703404
- Semantic Scholar
- 0c597199a9be21ad0a99933c6f411731493880d4
- Cited by
- 779
- References
- 26
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 19 · 2023: 18 · 2022: 22 · 2021: 23 · 2020: 27 · 2019: 27 · 2018: 31 · 2017: 35 · 2016: 51 · 2015: 59 · 2014: 50 · 2013: 40 · 2012: 57
- FWCI
- 40.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (32385)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- hyperinsulinemic hypoglycemia, nesidioblastosis, Roux-en-Y gastric bypass, postprandial hypoglycemia, neuroglycopenia, partial pancreatectomy, insulinoma, obesity
- MeSH terms
- Adult, Female, Follow-Up Studies, Humans, Hyperinsulinism, Hyperplasia, Hypoglycemia, Insulinoma, Islets of Langerhans, Male, Middle Aged, Obesity, Obesity, Morbid, Pancreatic Ducts, Pancreatic Neoplasms, Postoperative Complications, Gastric Bypass, Postprandial Period, Nesidioblastosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.